Administración Nacional de Medicamentos, Alimentos y Tecnología Médica
Argentine regulator and PIC/S member; its current GMP guide is ANMAT Disposición 4159/2023.
What this page does not claim
SPEQ curates and cross-references these bodies. It is not affiliated with, accredited by, or endorsed by any of them, and a count of decoded standards is a measure of SPEQ’s coverage, not of a body’s importance.
WHAT ANMAT COVERS
The Administración Nacional de Medicamentos, Alimentos y Tecnología Médica regulates medicines, food, and medical technology in Argentina. Its current GMP guide for human-use medicines is Disposición ANMAT 4159/2023, which consolidated and replaced several earlier dispositions.
WHAT ANMAT PUBLISHES
- 01Disposición 4159/2023 — the consolidated GMP guide for medicines
- 02Farmacopea Argentina
- 03Dispositions covering registration, importation, and specific product categories
- 04Establishment and product authorisation records
- 05Safety alerts and recall notices
HOW ITS REQUIREMENTS BITE
ANMAT authorises establishments and products and inspects manufacturers supplying the Argentine market. As one of the longest-standing PIC/S members in the region, its inspection approach follows the PIC/S model, and its GMP guide is explicitly built on WHO, PIC/S, ICH, and ISO sources.
What practitioners get wrong
- Work from the consolidated Disposición 4159/2023, not the repealed dispositions it replaced — earlier texts still circulate in supplier files and audit packs.
- Argentina has been a PIC/S member since 2008 — among the earliest in Latin America, which is why its inspection style will feel familiar to anyone who has hosted an EU inspection.
- The guide is explicitly PIC/S- and ICH-aligned, so an EU- or PIC/S-compliant quality system maps closely; the gap is usually documentation language and local establishment authorisation, not technical requirements.
- Spanish-language documentation is expected, and translation quality is itself an inspection risk when a translated procedure diverges from the controlled original.
- Establishment authorisation and product registration are separate acts — a site can be authorised while a specific product is not yet registered.
What an inspection under this authority actually probes
WHERE IT SITS INTERNATIONALLY
ANMAT is a PIC/S participating authority and builds its GMP guide on WHO, PIC/S, and ICH sources, making it one of the more internationally harmonised regulators in the region. For a CDMO or contract laboratory serving both Mercosur and export markets, that alignment means one quality system can generally satisfy both — provided local authorisation and language obligations are handled explicitly.
ANMAT STANDARDS SPEQ DECODES · 1
DISCIPLINES IN ANMAT’S REMIT
ANMAT: frequently asked questions
Reference answers on Administración Nacional de Medicamentos, Alimentos y Tecnología Médica’s mandate, what it publishes, and how its requirements acquire force.
What is ANMAT’s current GMP guide?
Disposición ANMAT 4159/2023 is the consolidated GMP guide for human-use medicines, which replaced several earlier dispositions. Work from the consolidated text, not the repealed dispositions it replaced, which still circulate in supplier files and audit packs.
When did Argentina join PIC/S?
Argentina has been a PIC/S participating authority since 2008 — among the earliest in Latin America. Its inspection approach follows the PIC/S model, so its inspection style feels familiar to anyone who has hosted an EU inspection.
Is ANMAT’s GMP guide internationally aligned?
Yes. The guide is explicitly built on WHO, PIC/S, ICH, and ISO sources, so an EU- or PIC/S-compliant quality system maps closely. The gap is usually documentation language and local establishment authorisation, not technical requirements.